{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:47:50Z","timestamp":1778032070030,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Shire Development LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s40263-015-0291-6","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T07:22:34Z","timestamp":1446880954000},"page":"953-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit\/Hyperactivity Disorder? Results from a Randomized Controlled Trial"],"prefix":"10.1007","volume":"29","author":[{"given":"Mark A.","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Sikirica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Newcorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,7]]},"reference":[{"issue":"1","key":"291_CR1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","volume":"53","author":"SN Visser","year":"2014","unstructured":"Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, et al. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003\u20132011. J Am Acad Child Adoles Psychiatry. 2014;53(1):34\u201346.","journal-title":"J Am Acad Child Adoles Psychiatry."},{"issue":"5","key":"291_CR2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1542\/peds.105.5.1158","volume":"105","author":"American Academy of Pediatrics","year":"2000","unstructured":"American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit\/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000;105(5):1158\u201370.","journal-title":"Pediatrics."},{"issue":"4","key":"291_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1469-7610.1995.tb02320.x","volume":"36","author":"MA Stein","year":"1995","unstructured":"Stein MA, Szumowski E, Blondis TA, Roizen NJ. Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry. 1995;36(4):663\u201370.","journal-title":"J Child Psychol Psychiatry."},{"issue":"1","key":"291_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-3-1","volume":"3","author":"E Parens","year":"2009","unstructured":"Parens E, Johnston J. Facts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversies. Child Adolesc Psychiatry Ment Health. 2009;3(1):1.","journal-title":"Child Adolesc Psychiatry Ment Health."},{"issue":"5","key":"291_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1087054707314028","volume":"11","author":"RA Gathje","year":"2008","unstructured":"Gathje RA, Lewandowski LJ, Gordon M. The role of impairment in the diagnosis of ADHD. J Atten Disord. 2008;11(5):529\u201337.","journal-title":"J Atten Disord."},{"issue":"Suppl 2","key":"291_CR6","doi-asserted-by":"crossref","first-page":"S711","DOI":"10.1016\/S0924-977X(14)71147-2","volume":"24","author":"K Gajria","year":"2014","unstructured":"Gajria K, Livote E, Sikirica V, Reilly K, Erder MH. Validation of the Weiss Functional Impairment Rating Scale\u2014Parent Report Form in attention deficit\/hyperactivity disorder. Eur Neuropsychopharmacol. 2014;24(Suppl 2):S711.","journal-title":"Eur Neuropsychopharmacol."},{"issue":"2","key":"291_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12402-014-0158-6","volume":"7","author":"MC Tarak\u00e7\u0131o\u011flu","year":"2015","unstructured":"Tarak\u00e7\u0131o\u011flu MC, Cakin Memik N, Olgun NN, Aydemir O, Weiss MD. Turkish validity and reliability study of the Weiss Functional Impairment Rating Scale\u2013Parent Report. Atten Defic Hyperact Disord. 2015;7(2):129\u201339.","journal-title":"Atten Defic Hyperact Disord"},{"issue":"10","key":"291_CR8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40263-013-0095-5","volume":"27","author":"T Banaschewski","year":"2013","unstructured":"Banaschewski T, Soutullo C, Lecendreux M, Johnson M, Zuddas A, Hodgkins P, et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs. 2013;27(10):829\u201340.","journal-title":"CNS Drugs."},{"issue":"6","key":"291_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/JCP.0b013e31829c762b","volume":"33","author":"J Fuentes","year":"2013","unstructured":"Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, et al. Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit\/hyperactivity disorder. J Clin Psychopharmacol. 2013;33(6):766\u201374.","journal-title":"J Clin Psychopharmacol."},{"issue":"2","key":"291_CR10","first-page":"86","volume":"20","author":"S Baer","year":"2011","unstructured":"Baer S, Bogusz E, Green DA. Stuck on screens: patterns of computer and gaming station use in youth seen in a psychiatric clinic. J Can Acad Child Adolesc Psychiatry. 2011;20(2):86\u201394.","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"issue":"7","key":"291_CR11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/1087054711416800","volume":"16","author":"J Hantson","year":"2012","unstructured":"Hantson J, Wang PP, Grizenko-Vida M, Ter-Stepanian M, Harvey W, Joober R, et al. Effectiveness of a therapeutic summer camp for children with ADHD: Phase I Clinical Intervention Trial. J Atten Disord. 2012;16(7):610\u20137.","journal-title":"J Atten Disord."},{"issue":"6","key":"291_CR12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/cap.2011.0018","volume":"21","author":"MA Stein","year":"2011","unstructured":"Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, et al. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child Adolesc Psychopharmacol. 2011;21(6):581\u20138.","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"6","key":"291_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/cap.2008.0166","volume":"19","author":"M Maziade","year":"2009","unstructured":"Maziade M, Rouleau N, Lee B, Rogers A, Davis L, Dickson R. Atomoxetine and neuropsychological function in children with attention-deficit\/hyperactivity disorder: results of a pilot study. J Child Adolesc Psychopharmacol. 2009;19(6):709\u201318.","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"291_CR14","doi-asserted-by":"crossref","unstructured":"Nagy P, Hage A, Coghill DR, Caballero B, Adeyi B, Anderson CS, et al. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder and an inadequate response to methylphenidate. Eur Child Adolesc Psychiatry. 2015. [Epub ahead of print].","DOI":"10.1007\/s00787-015-0718-0"},{"issue":"1","key":"291_CR15","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2006-3695","volume":"121","author":"J Biederman","year":"2008","unstructured":"Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder. Pediatrics. 2008;121(1):e73\u201384.","journal-title":"Pediatrics."},{"issue":"2","key":"291_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CHI.0b013e318191769e","volume":"48","author":"FR Sallee","year":"2009","unstructured":"Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit\/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155\u201365.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"1","key":"291_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaac.2011.10.012","volume":"51","author":"TE Wilens","year":"2012","unstructured":"Wilens TE, Bukstein O, Brams M, Cutler AJ, Childress A, Rugino T, et al. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):74\u201385.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"9","key":"291_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaac.2013.06.006","volume":"52","author":"JH Newcorn","year":"2013","unstructured":"Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, et al. Randomized, double-blind trial of guanfacine extended release in children with attention-deficit\/hyperactivity disorder: morning or evening administration. J Am Acad Child Adolesc Psychiatry. 2013;52(9):921\u201330.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"291_CR19","unstructured":"The Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Weiss Functional Impairment Rating Scale (WFIRS) instructions. http:\/\/www.caddra.ca\/cms4\/pdfs\/caddraGuidelines2011WFIRSInstructions.pdf . Accessed June 25 2015."},{"key":"291_CR20","unstructured":"The Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). Weiss Functional Impairment Rating Scale\u2014Parent Report (WFIRS-P). http:\/\/www.caddra.ca\/cms4\/pdfs\/caddraGuidelines2011WFIRS_P.pdf . Accessed June 25 2015."},{"issue":"1","key":"291_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139.","journal-title":"Psychol Bull."},{"issue":"4","key":"291_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaac.2014.12.016","volume":"54","author":"R Vidal","year":"2015","unstructured":"Vidal R, Castells J, Richarte V, Palomar G, Garcia M, Nicolau R, et al. Group therapy for adolescents with attention-deficit\/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(4):275\u201382.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"12","key":"291_CR23","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.euroneuro.2014.09.014","volume":"24","author":"A Hervas","year":"2014","unstructured":"Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, et al. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, controlled, phase III trial. Eur Neuropsychopharmacol. 2014;24(12):1861\u201372.","journal-title":"Eur Neuropsychopharmacol."},{"key":"291_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7525-10-47","volume":"10","author":"M Brod","year":"2012","unstructured":"Brod M, Pohlman B, Lasser R, Hodgkins P. Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes. 2012;10:47.","journal-title":"Health Qual Life Outcomes."},{"issue":"1","key":"291_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1753-2000-2-31","volume":"2","author":"D Coghill","year":"2008","unstructured":"Coghill D, Soutullo C, d\u2019Aubuisson C, Preuss U, Lindback T, Silverberg M, et al. Impact of attention-deficit\/hyperactivity disorder on the patient and family: results from a European survey. Child Adolesc Psychiatry Ment Health. 2008;2(1):31.","journal-title":"Child Adolesc Psychiatry Ment Health."},{"key":"291_CR26","volume-title":"Contemporary Trends in ADHD Research","author":"K Holmberg","year":"2012","unstructured":"Holmberg K. Adolescent academic outcome of childhood attention-deficit\/hyperactivity disorder\u2014a population-based study. In: Norvilitis JM, editor. Contemporary Trends in ADHD Research. Rijeka: InTech; 2012."},{"issue":"10","key":"291_CR27","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaac.2012.07.008","volume":"51","author":"JA Doshi","year":"2012","unstructured":"Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, et al. Economic impact of childhood and adult attention-deficit\/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry. 2012;51(10):990\u20131002.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"7","key":"291_CR28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/1087054711413074","volume":"16","author":"B Gjervan","year":"2012","unstructured":"Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. Functional impairment and occupational outcome in adults with ADHD. J Atten Disord. 2012;16(7):544\u201352.","journal-title":"J Atten Disord."},{"issue":"8","key":"291_CR29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S2215-0366(15)00271-0","volume":"2","author":"S Dalsgaard","year":"2015","unstructured":"Dalsgaard S, Leckman JF, Mortensen PB, Nielsen HS, Simonsen M. Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. Lancet Psychiatry. 2015;2(8):702\u20139.","journal-title":"Lancet Psychiatry."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0291-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0291-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T10:01:52Z","timestamp":1567332112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0291-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0291-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}